Bellevue Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-18,000
| Closed | -$1.25M | – | 143 |
|
|
2018
Q3 | $1.25M | Sell |
18,000
-15,000
| -45% | -$1.04M | 0.08% | 120 |
|
|
2018
Q2 | $2.5M | Hold |
33,000
| – | – | 0.21% | 81 |
|
|
2018
Q1 | $1.74M | Hold |
33,000
| – | – | 0.17% | 86 |
|
|
2017
Q4 | $1.76M | Sell |
33,000
-48,550
| -60% | -$2.59M | 0.18% | 86 |
|
|
2017
Q3 | $4.86M | Sell |
81,550
-50,440
| -38% | -$3.01M | 0.51% | 55 |
|
|
2017
Q2 | $10.4M | Buy |
131,990
+64,290
| +95% | +$5.07M | 1.23% | 31 |
|
|
2017
Q1 | $5.62M | Buy |
67,700
+27,000
| +66% | +$2.24M | 0.75% | 48 |
|
|
2016
Q4 | $3.23M | Buy |
40,700
+11,700
| +40% | +$928K | 0.66% | 43 |
|
|
2016
Q3 | $2.03M | Buy |
+29,000
| New | +$2.03M | 0.37% | 74 |
|